Ostatní
Návod 
Syndax Pharmaceuticals, Inc.
SNDX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.4B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-270%
ROA
-56%
PE
-7
PS
12
Cena 1R
9-23
⌀ Cena
14.27
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
02-03-2026
Poslední dividenda
Profil
Syndax Pharmaceuticals, Inc., biofarmaceutická společnost v klinickém stadiu, vyvíjí terapie pro léčbu rakoviny. Jeho hlavními kandidáty jsou SNDX- 5613, který je v klinické studii fáze 1/2 zaměřený na vazbu Meninu s leukémií 1 bílkovinou smíšené linie pro léčbu MLL-rearanžované (MLLr) a nukleosofminem 1 mutantní akutní myeloidní leukémie (NPM1c AML); a SNDX- 6352 nebo axatilimab, monoklonální protilátka blokující faktor stimulující kolonie 1, nebo receptor CSF- 1 pro léčbu pacientů s chronickým štěpem onemocnění hostitele (cGVHD). Společnost také vyvíjí Entinostat. Má také dohodu o spolupráci v oblasti výzkumu a vývoje s National Cancer Institute; dohodu o klinickém hodnocení s Eastern Cooperative Oncology Group; a licenční smlouvu s Kyowa Hakko Kirin Co., Ltd. Syndax Pharmaceuticals, Inc. byla začleněna v roce 2005 a má sídlo ve Walthamu, Massachusetts.Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
270
Založení
2016-03-02
Podobné společnosti
$ 6.24
+ $ 0.19
$ 77.02
- $ 3.67
$ 12.21
- $ 0.10
$ 12.37
+ $ 0.02
$ 56.14
+ $ 0.17
$ 3.97
- $ 0.12
$ 9.14
+ $ 0.09
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 172.4 | 172.4 | 23.7 | 0.0 | 0.0 | 139.7 | 1.5 | 1.5 | 1.5 | 2.1 | 1.2 | 0.6 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 7.0 | 7.0 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 165.4 | 165.4 | 22.9 | 0.0 | 0.0 | 139.7 | 1.5 | 1.5 | 1.5 | 2.1 | 1.2 | 0.6 | 0.0 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 68.5 | 45.9 | 38.0 | 20.0 | 7.7 | 12.5 | 3.5 | 0.0 | 0.5 | 0.0 | |
| Cost of Revenues | -1.6 | 6.4 | 1.3 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | |
| Gross Profit | 70.1 | 39.5 | 36.7 | 19.2 | 7.7 | 12.5 | 3.5 | 0.0 | 0.3 | 0.0 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 163.0 | 118.5 | 88.2 | 50.4 | 43.0 | 60.1 | 48.2 | 31.7 | 9.5 | 10.2 | 3.2 | 5.2 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 66.9 | 33.3 | 25.2 | 22.5 | 16.1 | 17.3 | 15.9 | 13.3 | 11.6 | 11.2 | 5.4 | 3.5 | |
| Depreciation & Amortization | 9.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Operating Expenses | 438.5 | 438.5 | 362.5 | 230.0 | 151.8 | 113.5 | 72.9 | 59.1 | 77.4 | 64.1 | 45.0 | 21.1 | 21.3 | 8.6 | 8.7 | |
| Operating Income | -273.1 | -273.1 | -339.7 | -230.0 | -151.8 | 26.2 | -71.4 | -57.5 | -75.9 | -62.0 | -43.8 | -20.5 | -21.3 | -8.6 | -8.7 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 55.1 | 39.1 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 22.8 | 17.3 | ||
| Depreciation & Amortization | 0.0 | 0.0 | 0.0 | 9.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Total Operating Expenses | 132.6 | 96.9 | 106.0 | 102.9 | 104.0 | 102.1 | 77.7 | 79.5 | 77.9 | 56.4 | ||
| Operating Income | -62.5 | -57.4 | -69.4 | -83.8 | -96.4 | -89.6 | -74.2 | -79.5 | -77.9 | -56.4 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 22.7 | 22.7 | 26.1 | 21.2 | 5.9 | 0.4 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 71.6 | 33.8 | 4.9 | 0.2 | 3.1 | 1.9 | 2.4 | 1.6 | 1.9 | 1.4 | 1.0 | 1.6 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -12.3 | -12.3 | 20.9 | 20.6 | 2.4 | -1.3 | -1.7 | 1.5 | 1.9 | 1.2 | -0.7 | -2.2 | 1.8 | -4.8 | 3.4 | |
| IBT | -285.4 | -285.4 | -318.8 | -209.4 | -149.3 | 24.9 | -73.2 | -56.0 | -74.0 | -60.8 | -44.5 | -24.1 | -19.8 | -14.2 | -10.0 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | -5.6 | 0.0 | -0.1 | -0.1 | 1.9 | -0.1 | -0.1 | 1.5 | -1.5 | 2.6 | 1.2 | |
| Net Income | -285.4 | -285.4 | -318.8 | -209.4 | -143.7 | 24.9 | -73.1 | -56.0 | -74.0 | -60.8 | -44.5 | -24.1 | -19.8 | -14.2 | -10.0 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 9.6 | 0.0 | 6.0 | 7.2 | 7.1 | 5.4 | 6.3 | 7.3 | 5.6 | 5.3 | ||
| Interest Expense | 52.7 | 3.0 | 7.9 | 8.1 | 4.8 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | ||
| Other Expense | -5.5 | -3.3 | -2.5 | -1.1 | 2.2 | 5.5 | 6.2 | 7.1 | 5.4 | 5.2 | ||
| IBT | -68.0 | -60.7 | -71.8 | -84.8 | -94.2 | -84.1 | -68.1 | -72.4 | -72.5 | -51.1 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.0 | 0.0 | ||
| Net Income | -68.0 | -60.7 | -71.8 | -84.8 | -94.2 | -84.1 | -68.1 | -72.4 | -72.5 | -51.1 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.98 | $-2.37 | $0.48 | $-1.77 | $-1.84 | $-2.92 | $-2.90 | $-3.04 | $-1.39 | $-2.07 | $-1.77 | $-0.14 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.98 | $-2.37 | $0.48 | $-1.77 | $-1.84 | $-2.92 | $-2.90 | $-3.04 | $-1.39 | $-2.07 | $-1.77 | $-0.14 | |
| Shares Outstanding | 86.6 | 86.6 | 85.6 | 70.4 | 60.8 | 52.1 | 41.3 | 30.5 | 25.4 | 21.0 | 14.6 | 17.4 | 9.6 | 8.0 | 70.3 | |
| Diluted Shares Outstanding | 86.6 | 86.6 | 85.6 | 70.4 | 60.8 | 52.1 | 41.3 | 30.5 | 25.4 | 21.0 | 14.6 | 17.4 | 9.6 | 8.0 | 70.3 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.00 | $-0.73 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.00 | $-0.73 | ||
| Shares Outstanding | 86.6 | 86.6 | 86.3 | 85.6 | 85.8 | 85.4 | 85.3 | 85.2 | 72.5 | 69.9 | ||
| Diluted Shares Outstanding | 86.6 | 86.6 | 86.3 | 85.6 | 85.8 | 85.4 | 85.3 | 85.2 | 72.5 | 69.9 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 105.4 | 154.1 | 295.4 | 74.4 | 222.0 | 115.2 | 24.6 | 33.8 | 35.2 | 23.8 | 23.2 | 10.0 | 10.1 | 0.5 | |
| Short Term Investments | 319.7 | 428.8 | 282.2 | 410.0 | 218.0 | 177.8 | 35.2 | 47.1 | 94.8 | 81.5 | 64.1 | 2.2 | 4.2 | 0.1 | |
| Total Cash & ST Investments | 425.1 | 582.9 | 577.6 | 481.3 | 439.9 | 293.1 | 59.8 | 80.9 | 133.2 | 105.3 | 87.3 | 12.2 | 14.3 | 0.6 | |
| Accounts Receivable | 10.9 | 13.9 | 1.2 | 4.1 | 0.4 | 0.2 | 0.1 | 0.3 | 0.4 | 0.3 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.4 | 0.0 | -4.3 | 7.7 | 5.3 | 1.7 | 1.1 | -1.4 | 2.4 | 0.3 | 0.1 | 0.0 | 0.0 | |
| Other Current Assets | 10.1 | 5.9 | 2.1 | 0.2 | 0.4 | 0.3 | 0.8 | 1.1 | 1.3 | 0.5 | 0.2 | 0.2 | 0.3 | 0.1 | |
| Total Current Assets | 446.1 | 603.1 | 580.9 | 481.3 | 448.4 | 298.9 | 62.3 | 83.3 | 133.4 | 108.5 | 88.0 | 12.4 | 14.5 | 0.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 116.8 | 108.6 | 154.0 | 154.1 | 133.0 | 105.4 | 114.6 | 295.4 | 94.6 | 97.3 | |
| Short Term Investments | 337.4 | 360.1 | 362.3 | 428.8 | 256.6 | 319.7 | 320.0 | 282.2 | 279.3 | 308.7 | |
| Total Cash & ST Investments | 454.2 | 468.7 | 516.3 | 582.9 | 389.6 | 425.1 | 434.6 | 577.6 | 373.8 | 406.0 | |
| Accounts Receivable | 25.4 | 37.4 | 21.5 | 13.9 | 4.7 | 10.9 | 7.6 | 1.2 | 4.2 | 0.5 | |
| Inventory | 27.5 | 17.7 | 4.7 | 0.4 | 0.0 | 0.0 | 0.0 | 2.0 | 2.7 | 2.2 | |
| Other Current Assets | 22.7 | 7.9 | 6.3 | 5.9 | 20.5 | 10.1 | 11.7 | 2.1 | 3.0 | 2.5 | |
| Total Current Assets | 529.8 | 531.7 | 548.8 | 603.1 | 414.8 | 446.1 | 453.9 | 580.9 | 381.0 | 409.1 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 1.0 | 2.0 | 1.5 | 1.1 | 1.3 | 0.5 | 1.0 | 0.4 | 0.3 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 29.7 | 119.5 | 29.8 | 5.5 | 0.0 | 0.0 | 0.0 | 0.0 | 3.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.2 | 0.2 | 0.7 | 9.4 | 0.0 | 1.3 | 0.2 | 0.2 | 0.2 | 0.2 | 1.8 | 0.3 | 2.5 | 0.8 | |
| Total Long-Term Assets | 30.9 | 121.8 | 32.0 | 16.0 | 1.3 | 1.7 | 1.2 | 0.6 | 3.7 | 0.5 | 1.9 | 0.4 | 2.5 | 0.8 | |
| Total Assets | 476.9 | 724.8 | 612.9 | 497.2 | 449.7 | 300.6 | 63.5 | 83.9 | 137.2 | 109.0 | 89.9 | 12.8 | 17.1 | 1.5 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 1.6 | 1.6 | 1.8 | 2.0 | 0.8 | 1.0 | 1.2 | 1.5 | 1.7 | 2.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 20.1 | 62.6 | 89.9 | 119.5 | 10.0 | 29.7 | 87.6 | 29.8 | 15.7 | 19.5 | |
| Other Long-Term Assets | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.7 | 0.8 | 0.8 | |
| Total Long-Term Assets | 22.0 | 64.5 | 92.0 | 121.8 | 11.0 | 30.9 | 89.1 | 32.0 | 18.3 | 22.3 | |
| Total Assets | 551.8 | 596.1 | 640.7 | 724.8 | 425.8 | 476.9 | 543.0 | 612.9 | 399.2 | 431.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 11.6 | 11.6 | 10.0 | 4.4 | 5.7 | 3.5 | 6.2 | 1.4 | 2.2 | 2.4 | 1.5 | 0.4 | 1.1 | 0.8 | |
| Short-Term Debt | 1.0 | 12.6 | 1.0 | 0.4 | 0.4 | 2.6 | 0.5 | 13.0 | 11.8 | 6.4 | 1.9 | 6.4 | 0.0 | 21.3 | |
| Other Current Liabilities | 29.9 | 79.3 | 47.1 | 24.3 | 1.9 | 11.2 | 10.2 | 0.1 | 0.2 | 0.4 | 0.3 | 0.2 | 1.7 | 0.6 | |
| Current Liabilities | 42.5 | 103.5 | 58.1 | 29.1 | 20.7 | 18.9 | 18.4 | 16.1 | 15.8 | 10.4 | 4.8 | 10.3 | 2.7 | 25.1 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 13.8 | 17.4 | 10.0 | 11.6 | 4.9 | 11.6 | 8.8 | 10.0 | 6.0 | 11.0 | |
| Short-Term Debt | 23.3 | 0.4 | 0.4 | 12.6 | 0.9 | 1.0 | 1.1 | 1.0 | 1.0 | 1.0 | |
| Other Current Liabilities | 77.1 | 95.3 | 84.1 | 79.3 | 53.6 | 29.9 | 40.9 | 47.1 | 32.1 | 18.2 | |
| Current Liabilities | 114.2 | 113.0 | 94.6 | 103.5 | 59.4 | 42.5 | 50.8 | 58.1 | 39.2 | 30.2 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.1 | 333.1 | 0.6 | 0.7 | 20.6 | 17.9 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 7.4 | 0.0 | 0.0 | |
| Capital Leases | 0.1 | 2.1 | 1.6 | 1.2 | 1.1 | 0.4 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 42.6 | 436.7 | 58.7 | 29.8 | 41.3 | 48.4 | 31.9 | 30.9 | 32.9 | 24.9 | 23.2 | 18.5 | 5.2 | 30.8 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 322.2 | 1.3 | 1.5 | 333.1 | 0.0 | 0.1 | 0.3 | 0.6 | 0.9 | 1.1 | |
| Capital Leases | 1.5 | 1.7 | 1.8 | 2.1 | 0.9 | 0.1 | 0.3 | 1.6 | 1.9 | 2.1 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 436.4 | 438.7 | 425.6 | 436.7 | 59.4 | 42.6 | 51.1 | 58.7 | 40.0 | 31.3 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,042.9 | -1,221.2 | -902.4 | -693.0 | -543.7 | -568.6 | -495.5 | -439.4 | -366.1 | -305.3 | -259.7 | -159.8 | -135.7 | -79.1 | |
| Comprehensive Income | -0.8 | 0.2 | 0.2 | -0.8 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.1 | 0.0 | -0.2 | -0.2 | -0.2 | |
| Total Common Equity | 434.3 | 288.1 | 554.2 | 467.4 | 408.4 | 252.2 | 31.6 | 53.0 | 104.3 | 84.1 | 66.7 | -5.7 | 11.8 | -29.3 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,438.6 | -1,377.9 | -1,306.0 | -1,221.2 | -1,127.0 | -1,042.9 | -974.8 | -902.4 | -829.9 | -778.8 | |
| Comprehensive Income | 0.5 | 0.3 | 0.5 | 0.2 | 0.4 | -0.8 | -0.8 | 0.2 | -0.5 | -0.6 | |
| Total Common Equity | 115.4 | 157.4 | 215.1 | 288.1 | 366.4 | 434.3 | 491.9 | 554.2 | 359.2 | 400.0 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 1.1 | 345.7 | 1.6 | 1.2 | 21.0 | 20.5 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 13.9 | 0.0 | 21.3 | |
| Book Value | 434.3 | 288.1 | 554.2 | 467.4 | 408.4 | 252.2 | 31.6 | 53.0 | 104.3 | 84.1 | 66.7 | -5.7 | 11.8 | -29.3 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 115.4 | 157.4 | 215.1 | 288.1 | 366.4 | 434.3 | 491.9 | 554.2 | 359.2 | 400.0 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -264.1 | -285.4 | -318.8 | -209.4 | -149.3 | 24.9 | -73.2 | -56.0 | -74.0 | -60.8 | -44.5 | -24.1 | -19.8 | -14.2 | -10.0 | |
| Depreciation & Amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Stock-Based Compensation | 35.4 | 47.5 | 43.0 | 31.0 | 16.0 | 13.3 | 9.1 | 6.0 | 6.2 | 5.5 | 4.7 | 3.9 | 2.3 | 1.4 | 0.1 | |
| Change Working Capital | 1.1 | -79.3 | 13.3 | 31.9 | 1.7 | -9.6 | -7.9 | -0.2 | -0.3 | 7.7 | 2.9 | 14.6 | 0.6 | 0.0 | 0.8 | |
| Change In Accounts Receivable | -17.7 | -36.8 | -11.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 0.6 | 5.0 | 1.7 | 5.6 | -1.3 | 2.2 | -2.7 | 4.7 | -0.8 | -0.2 | 0.9 | 1.0 | -0.7 | -0.3 | 0.0 | |
| Change In Inventories | 4.0 | -32.1 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 13.6 | -5.7 | -12.4 | -14.1 | -2.0 | 0.2 | 0.8 | 0.4 | 0.0 | 0.0 | 0.0 | 0.8 | 0.0 | 3.7 | 3.1 | |
| Cash from Operations | -241.2 | 0.0 | 0.0 | -160.6 | -133.7 | 29.1 | -71.3 | -50.6 | -68.5 | -47.4 | -35.2 | -2.4 | -14.4 | -7.3 | -9.3 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -68.0 | -60.7 | -71.8 | -84.8 | -94.2 | -84.1 | -68.1 | -72.4 | -72.5 | -51.1 | |
| Depreciation & Amortization | 0.0 | -0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Stock-Based Compensation | 11.3 | 12.1 | 13.8 | 10.4 | 12.3 | 11.9 | 9.9 | 8.9 | 8.3 | 8.3 | |
| Change Working Capital | -11.8 | -23.4 | -26.8 | -17.4 | 27.2 | 12.6 | -10.1 | -16.5 | 26.0 | 1.6 | |
| Change In Accounts Receivable | -19.0 | -6.0 | -3.8 | -8.1 | -6.0 | 4.3 | -3.5 | -6.1 | -0.1 | -3.9 | |
| Change In Accounts Payable | 2.8 | -3.5 | 7.3 | -1.6 | 6.7 | -6.7 | 2.8 | -1.2 | 3.9 | -4.9 | |
| Change In Inventories | -7.8 | -7.2 | -12.9 | -4.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 3.9 | |
| Other Non-cash Items | -1.0 | 1.6 | -3.0 | -3.3 | -2.7 | -2.8 | -3.4 | -3.6 | -10.6 | 0.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -41.3 | -44.7 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | -0.2 | -0.1 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -379.4 | -195.8 | -557.1 | -354.6 | -495.3 | -294.7 | -278.9 | -104.0 | -78.8 | -152.3 | -158.3 | -102.0 | -3.4 | -4.0 | 0.0 | |
| Sales of Investment | 365.5 | 486.0 | 337.3 | 472.2 | 308.9 | 254.0 | 136.4 | 116.8 | 130.4 | 135.3 | 140.3 | 40.5 | 5.3 | 0.0 | 0.5 | |
| Other Investing Activities | -75.6 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -13.9 | 0.0 | 0.0 | 117.6 | -186.2 | -40.9 | -142.5 | 12.8 | 51.4 | -17.0 | -18.4 | -61.7 | 1.9 | -4.0 | 0.5 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -63.1 | -30.4 | -91.7 | -10.5 | -376.3 | -13.4 | 0.0 | -167.4 | -129.3 | -82.7 | |
| Sales of Investment | 144.8 | 103.0 | 133.6 | 104.7 | 107.3 | 100.2 | 61.8 | 68.0 | 113.0 | 122.8 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -16.3 | 40.1 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -16.3 | 40.1 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | -21.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -9.0 | 0.0 | -4.4 | -1.8 | |
| Debt Issued | -1.0 | 345.7 | 344.1 | 0.5 | 1.2 | 0.4 | 19.6 | 0.9 | 0.0 | 0.0 | 0.0 | -4.9 | 13.9 | -16.9 | 23.1 | |
| Issuance of Common Stock | 262.8 | 0.0 | 0.0 | 258.1 | 181.8 | 86.3 | 277.7 | 28.2 | 15.5 | 75.3 | 52.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 24.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 2.6 | 0.0 | 0.0 | 6.0 | 11.5 | 7.3 | 26.7 | 0.4 | 0.2 | 0.4 | 4.7 | 86.3 | 12.4 | 25.3 | 7.5 | |
| Cash from Financing | 263.2 | 0.0 | 0.0 | 264.1 | 172.3 | 118.5 | 304.4 | 28.6 | 15.7 | 75.7 | 54.2 | 77.3 | 12.4 | 20.9 | 5.7 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 345.4 | 343.8 | -0.2 | -343.9 | 344.9 | -0.3 | -0.3 | -0.2 | -0.2 | -0.2 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 258.1 | 1.9 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 1.9 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 258.5 | 1.9 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 8.1 | -19.3 | -141.3 | 221.1 | -147.6 | 106.7 | 90.6 | -9.3 | -1.4 | 11.3 | 0.7 | 13.2 | -0.1 | 9.6 | -3.1 | |
| Closing Cash Balance | 105.4 | 135.0 | 154.3 | 295.6 | 74.5 | 222.1 | 115.4 | 24.7 | 34.0 | 35.2 | 23.8 | 23.2 | 10.0 | 10.1 | 0.5 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 18.0 | 8.2 | -45.4 | -0.1 | 21.1 | 27.6 | -9.2 | -180.8 | 200.8 | -2.7 | |
| Closing Cash Balance | 135.0 | 117.0 | 108.9 | 154.2 | 154.3 | 133.2 | 105.6 | 114.8 | 295.6 | 94.8 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -241.2 | -323.2 | -274.9 | -160.6 | -133.7 | 29.0 | -71.3 | -50.6 | -68.7 | -47.5 | -35.4 | -2.5 | -14.4 | -7.3 | -9.3 | |
| Real Free Cash Flow | -276.6 | -370.7 | -317.9 | -191.6 | -149.7 | 15.7 | -80.3 | -56.6 | -74.9 | -52.9 | -40.1 | -6.4 | -16.7 | -8.7 | -9.4 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -69.5 | -70.7 | -87.8 | -95.2 | -57.4 | -62.3 | -71.6 | -83.5 | -41.3 | -44.7 | |
| Real Free Cash Flow | -80.8 | -82.7 | -101.6 | -105.5 | -69.7 | -74.3 | -81.5 | -92.4 | -49.7 | -53.0 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -7.4 | 52.4 | -1.4 |
| P/S | 12.2 | 248.6 | 9.4 |
| P/B | 18.2 | 4.2 | 5.2 |
| P/FCF | -5.7 | -12.3 | -1.5 |
| Market cap | $1.4 | $1.3 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 62.6 % | 7.1 % | 0 % |
| Debt to Income | -121 % | 58.7 % | 0 % |
| Debt to Free cash flow | -93.2 % | -3612.2 % | 0 % |
| Interest expense percentage | -26.2 % | 1.8 % | 44.7 % |
| Current ratio | 4.6 | 8.7 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -247.3 % | -47.2 % | 0 % |
| ROA | -51.7 % | -48.3 % | 0 % |
| CapEx to Revenue | 0.1 % | 4.5 % | 0 % |
| RaD to Revenue | 0 % | 3677.7 % | 0 % |
| ROEM | 638,340.7 | 145141.7 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 92.3 % | 40.6 % | 68.7 % |
| Operating margin | -275.1 % | -6462.3 % | 35.5 % |
| Net margin | -279.3 % | -6474.5 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.2 % | 0 % |
| Dividend payout percentage | 0 % | -0.4 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 86.6 mil | 48.0 mil |
| Employee count | 0.3 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
